http://​www ​ncbi ​nlm ​nih ​gov/​geo/​ 11 Colon cancer tissue m

http://​www.​ncbi.​nlm.​nih.​gov/​geo/​ 11. Colon cancer tissue microarray case sets. http://​dctd.​cancer.​gov/​ProgramPages/​cdp/​tools_​disease-specific.​htm 12. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando

Y, Kudo E, Shimada M, Sano T: High expression of Toll-like receptor 4/myeloid differentiation Ceritinib molecular weight factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 2010,102(5):908–915.PubMedCentralPubMedCrossRef 13. Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, Garlanda C, Laghi L, Barberis MC, Sessa F, Noonan DM, Albini A: The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Transl Med 2010, 8:112.PubMedCentralPubMedCrossRef 14. RDCTeam: R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010. 15. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995,57(1):289–300. 16. Troyanskaya OG, Garber ME, Brown PO, Botstein D, Altman BMS-777607 research buy RB: Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics (Oxford, England) 2002,18(11):1454–1461.CrossRef 17. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai

J, Kerr D, Aaltonen LA, Arango D, Kruhøffer M, Orntoft TF, Andersen CL, Gruidl M, Kamath VP, Eschrich S, Yeatman TJ, Sieber OM: Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin Cancer Res 2009,15(24):7642–7651.PubMedCentralPubMedCrossRef 18. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers

H, Marra G: Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007,5(12):1263–1275.PubMedCrossRef 19. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J: Modeling O-methylated flavonoid oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS ONE 2010.,5(10): 20. Lips EH, van Eijk R, de Graaf EJ, Oosting J, de Miranda NF, Karsten T, van de Velde CJ, Eilers PH, Tollenaar RA, van Wezel T, Morreau H: Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. BMC Cancer 2008, 8:314.PubMedCentralPubMedCrossRef 21. Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, Mori M: Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res 2012,18(11):3054–3070.PubMedCrossRef 22. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ: Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Comments are closed.